Pro B-type natriuretic peptide plasma value: A new criterion for the prediction of short- and long-term outcomes after transcatheter aortic valve implantation

International Journal of Cardiology

Volumn 168, Issue 2, 2013, Pages 1264-1268

  López Otero, Diego ^b   Trillo Nouche, Ramiro ^b   Gude, Francisco ^a   Cid Alvarez, Belen ^b   Ocaranza Sanchez, Raimundo ^b   Alvarez, Melisa Santas ^b   Lear, Pamela V ^b   Gonzalez Juanatey, José R ^b  

^a Clinical Epidemiology Unit   (Spain)

^b Pediatric Nutrition Research Group Health Research Institute of Santiago de Compostela   (Spain)

Author keywords

Aortic stenosis; EuroSCORE; Pro B type natriuretic peptide; Transcatheter aortic valve implantation

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ACCURACY; ACUTE KIDNEY FAILURE; AGED; AORTA STENOSIS; AORTA VALVE PROSTHESIS; ARTICLE; ATRIOVENTRICULAR BLOCK; CONTROLLED STUDY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; POSTOPERATIVE HEMORRHAGE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SURVIVOR; TRANSCATHETER AORTIC VALVE IMPLANTATION;

AORTIC STENOSIS; AS; BNP; CABG; CORONARY ARTERY BYPASS GRAFTING; EUROPEAN SYSTEM FOR CARDIAC OPERATIVE RISK EVALUATION; EUROSCORE; GFR; GLOMERULAR FILTRATION RATE; LES; LOG PRO-BNP; LOGARITHM OF PRO B-TYPE NATRIURETIC PEPTIDE; LOGISTIC EUROPEAN SYSTEM FOR CARDIAC OPERATIVE RISK EVALUATION; NEW YORK HEART ASSOCIATION; NYHA; PRO B-TYPE NATRIURETIC PEPTIDE; PRO-BNP; TAVI; TRANSCATHETER AORTIC VALVE IMPLANTATION;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; BIOLOGICAL MARKERS; CARDIAC CATHETERIZATION; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84885317013     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.11.116     Document Type: Article

References (19)

1. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease In Europe: the Euro Heart Survey on Valvular Heart disease. Eur Heart J 2003;24:1231-43.
2. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve Implantation for aortic stenosis In patients who cannot undergo surgery. N Engl J Med 2010;363: 1597-607.
3. Vahanian A, Alfieri O, Al-Attar N, et al. Transcatheter valve Implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), In collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCi). Eur J Cardiothorac Surg 2008;34:1-8.
4. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement In high-risk patients. N Engl J Med 2011;364:2187-98.
5. Roques F, Michel P, Goldstone AR, Nashef SAM. The logistic EuroSCORE (letter to editor). Eur Heart J 2003;24:1-2.
6. Osswald BR, Gegouskov V, Badowski D, et al. Overestimation of aortic valve replacement risk by EuroSCORE: Implications for percutaneous valve replacement. Eur Heart J 2009;30:74-80.
7. Rodes-Cabau J, Webb J, Cheung A, et al. Transcatether aortic valve Implantation for the treatment of severe symptomatic aortic stenosis In patients at very high or prohibitive surgical risk. J Am Coll Cardiol 2010;55:1080-90.
8. Masson S, Latini R, Anand IS, et al. Prognostic value of changes In N-terminal pro-brain natriuretic peptide In Val-HeFT (Valsartan Heart Failure Trial). J Am Coll Cardiol 2008;52(12):997-1003 [16].
9. Weber M, Arnold R, Rau M, et al. Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis. Am J Cardiol 2004;94:740-5.
10. Geber IL, Stewart RA, Legget ME, et al. Increased plasma natriuretic peptide levels reflect symptoms onset In aortic stenosis. Circulation 2003;107:1884-90.
11. Pedrazzini GB,Masson S, Latini R, et al. Comparison of brain natriuretic peptide plasma levels versus logistic EuroSCORE In predicting In-hospital and late postoperative mortality In patients undergoing aortic valve replacement for symptomatic aortic stenosis. Am J Cardiol Sep 15 2008;102:749-54.
12. Kefer J, Beauloye C, Astarci P, et al. Usefulness of B-type natriuretic peptide to predict outcome of patients treated by transcatheter aortic valve Implantation. Am J Cardiol 2010;106(12):1782-6.
13. Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement In selected high-risk patients with aortic stenosis. Circulation 2007;116:755-63.
14. López-Otero D, Muñoz-García AJ, Avanzas P, et al. Axillary approach for transcatheter aortic valve Implantation: optimization of the endovascular treatment for the aortic valve stenosis. Rev Esp Cardiol 2011;64:121-6.
15. Heagerty PJ, Zheng Y. Survivalmodel predictive accuracy and ROC curves. Biometrics 2005;61:92-105.
16. Haibe-Kains, Desmedt C, Sotiriou C, Bontempi G. A comparative study of survival models for breast cancer prognostication based on microarray data: does a single gene beat them all? Bioinformatics 2008;24:2200-8.
17. Leon MB, Piazza N, Nikolsky E, et al. Standardized endpoInt definitions for transcatheter aortic valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J Jan 2011;32(2):205-17.
18. Coeytaux RM, Williams JW, Gray NR, Wang A. A percutaneous heart valve replacement for aortic stenosis: state of the evidence. Ann Intern Med 2010;153:314-24.
19. Bergler-Klein J, Klaar U, Heger M, et al. Natriuretic peptides predict symptom-free survival and postoperatori outcome In severe aortic stenosis. Circulation 2004;109: 2302-8.